Answers are grounded in this paper and cite their sources.
providers caring for recipients of organs from donors who are HCV-seropositive or recently injected drugs should maintain awareness of infectious complications of injection drug use and monitor recipients accordingly (2). In addition to testing for HBV DNA at 4-6 weeks after transplantation, clinicians caring for liver transplant recipients should consider testing for HBV DNA 1 year after transplantation or at any time if signs and symptoms of viral hepatitis develop, even if previous tests were negative (2).
No takes yet. Share an insight, caveat, or question.
Bixler et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: